Achieve Life Sciences, Inc. (ACHV)
5.40
-0.07
(-1.28%)
USD |
NASDAQ |
Jan 09, 14:28
Achieve Life Sciences Free Cash Flow: -40.68M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| StimCell Energetics, Inc. | -0.2291M |
| Venus Concept, Inc. | -20.75M |
| Oncolytics Biotech, Inc. | -18.79M |
| Aurinia Pharmaceuticals, Inc. | 120.39M |
| Edesa Biotech, Inc. | -7.434M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.33M |
| Cash from Investing (Quarterly) | -12.65M |
| Cash from Financing (Quarterly) | 4.042M |
| Free Cash Flow Per Share (Quarterly) | -0.2221 |
| Free Cash Flow to Equity (Quarterly) | -11.33M |
| Free Cash Flow to Firm (Quarterly) | -11.14M |
| Free Cash Flow Yield | -19.45% |